Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - sigalaste immunoloogilised omadused - sead - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 250mg+62,5mg 50tk; 250mg+62,5mg 100tk; 250mg+62,5mg 250tk; 250mg+62,5mg 30tk

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 50mg+12,5mg 50tk; 50mg+12,5mg 10tk; 50mg+12,5mg 250tk; 50mg+12,5mg 100tk; 50mg+12,5mg 30tk

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 500mg+125mg 30tk; 500mg+125mg 10tk; 500mg+125mg 50tk; 500mg+125mg 100tk; 500mg+125mg 250tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - sead - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Eesti - eesti - Ravimiamet

intervet international b.v. - tsefapiriin - intramammaarsuspensioon - 300mg 20tk; 300mg 144tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psühhoeptikumid, uinutid ja rahustid - koerad - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

Eesti - eesti - Ravimiamet

vetoquinol s.a. - tolfenaamhape - süstelahus - 80mg 1ml 250ml 1tk; 80mg 1ml 100ml 1tk; 80mg 1ml 50ml 1tk

Eesti - eesti - Ravimiamet

huvepharma - tulatromütsiin - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 250ml 1tk

Eesti - eesti - Ravimiamet

huvepharma - tulatromütsiin - süstelahus - 25mg 1ml 250ml 1tk; 25mg 1ml 100ml 1tk; 25mg 1ml 50ml 1tk